Phrase | Consultant | Town | Special Interests |
clinical e-health | *Consultant(s)* | *Towns* | HIV medicine, epidemiology of sexually transmitted infections, clinical e-health, new diagnostic platforms for STIs |
Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics | Clinical Genetics | *Consultant(s)* | *Towns* | Learning disability, dermatology | Clinical Genetics | *Consultant(s)* | *Towns* | Neuromuscular genetics | Clinical Genetics | *Consultant(s)* | *Towns* | Duchenne muscular dystrophy family screening | Clinical Genetics | *Consultant(s)* | *Towns* | Cortical malformations - brain, neuronal migration disorders | Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics, research | Clinical governance | *Consultant(s)* | *Towns* | Clinical governance | clinical governance | *Consultant(s)* | *Towns* | Intensive care, clinical governance | clinical governance/risk management | *Consultant(s)* | *Towns* | Medical management, clinical governance/risk management, maternal and fetal medicine, ultrasound | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Epilepsy, peripheral nerve disorders | Clinical Neurophysiology | *Consultant(s)* | *Towns* | Nerve conduction studies, epilepsy, peripheral nerve and muscle disease | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast malignancies, urological malignancies | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, urological cancer, renal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, chemotherapy, immunotherapy, metastatic cancer, lung cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, upper gastrointestinal malignancy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, tumours of the thorax and lower gastrointestinal tract | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer and mesothelioma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, neuro-oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, bladder cancer, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, soft tissue and bone sarcomas, oropharyngeal cancer, laryngeal/hypopharyngeal cancer, head and neck sarcomas, salivary gland cancers, gastrointestinal stromal tumours (GIST), late radiotherapy toxicity, survivorship - resilience for patients | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, lymphoma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, endocrine cancers, endometrial cancer, cervical cancer, ovarian cancer, thyroid, gynaecological sarcomas | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, management of cervical cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, eye cancer, head and neck cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological malignancy, skin cancers | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, breast cancer, rare cancers | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical Pharmacology | *Consultant(s)* | *Towns* | General medicine | clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | Prevention and management of acute stroke, blood pressure, clinical pharmacology and therapeutics | Clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | Clinical pharmacology and therapeutics | clinical pharmacology and therapeutics | *Consultant(s)* | *Towns* | Acute care, clinical pharmacology and therapeutics, diabetes, endocrinology | Clinical psychology | *Consultant(s)* | *Towns* | Clinical psychology, cognitive therapy, PTSD - post-traumatic stress disorder, adjustment to physical illness, adult mental health, healthcare governance, medical and healthcare law, personal injuries - legal claims, long term consequences of abuse and trauma, asylum and immigration, housing instability, historical abuse claims | Clinical radiology | *Consultant(s)* | *Towns* | Clinical radiology, colorectal cancer radiology | clinical risk management for suicide | *Consultant(s)* | *Towns* | Depression, stigma of mental illness, prevention in mental illness, clinical risk management for suicide, adult consequences of childhood trauma and abuse |